XML 64 R54.htm IDEA: XBRL DOCUMENT v3.22.2
Stockholders' Equity - Narrative (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 24, 2022
Jun. 25, 2021
Jun. 24, 2022
Jun. 25, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based compensation expense, capitalized     $ 0  
Number of shares available for grant (in shares) 2,088,866   2,088,866  
Restricted Stock        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares granted (in shares)     489,344  
Weighted average grant date fair value (in usd per share)     $ 30.50  
Recognized expense $ 2,939,000 $ 3,280,000 $ 5,982,000 $ 5,738,000
Total unrecognized compensation cost, RSAs 23,850,000   $ 23,850,000  
Weighted average remaining term (in years)     2 years 2 months 12 days  
Time , Market, And Performance Based Grants | Maximum        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Vesting period (in years)     4 years  
Time-based        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares granted (in shares)     154,822  
Weighted average grant date fair value (in usd per share)     $ 27.32  
Total unrecognized compensation cost, RSAs 11,916,000   $ 11,916,000  
Weighted average remaining term (in years)     2 years 1 month 6 days  
Performance-based        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares granted (in shares)     167,261  
Weighted average grant date fair value (in usd per share)     $ 32.44  
Total unrecognized compensation cost, RSAs $ 11,934,000   $ 11,934,000  
Weighted average remaining term (in years)     2 years 2 months 12 days